相关实验视频
Updated: Feb 26, 2026

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
5.4K
新兴的目标和治疗多克索鲁比诱导的心脏炎症
Thawatchai Khuanjing1,2,3, Siriporn C Chattipakorn1,3,4, Nipon Chattipakorn1,2,3,5
1Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand.
Journal of inflammation research
|February 25, 2026
概括
多克索鲁比 (DOX) 化疗会导致心脏损伤,但新的研究表明微RNA (miRNA),圆形RNA (circRNA) 和外体细胞可以对抗这种炎症. 这些分子提供了有希望的向策略,可以在癌症治疗期间保护心脏.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 多克索鲁比 (DOX) 是一种重要的化疗药物,但由于剂量依赖性心脏毒性,其使用受到限制.
- 炎症是DOX诱导心脏毒性的关键因素,恶化氧化应激并导致心力衰竭.
- 目前对DOX心脏毒性的治疗方法缺乏向的抗炎方法.
研究的目的:
- 审查非编码RNAs (miRNAs,circRNAs) 和外体在DOX诱导心脏毒性的抗炎作用.
- 突出这些分子的机械路径和治疗潜力.
- 确定这些新策略的临床翻译的挑战.
主要方法:
- 在DOX心脏毒性中对miRNAs,circRNAs和exosomes进行实验研究的文献综述.
- 对涉及NF-κB,Nrf2和亡途径的分子机制的分析.
- 对治疗分子的外体介导输送的评估.
主要成果:
- 特定的miRNA和circRNA显示出抗炎作用,减少细胞因子的产生和氧化损伤.
- 这些分子增强了DOX暴露模型中的心肌细胞存活率.
- 基于外体的输送系统显示了减轻DOX诱导的心肌损伤的潜力.
结论:
- 微RNA,circRNA和外体组代表了对DOX心脏毒性的有希望的向抗炎策略.
- 需要进一步的研究来克服临床应用的挑战.
- 这些新的方法可以改善癌症幸存者的结果.
相关概念视频
Heart Failure Drugs: Inotropic Agents
1.6K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.6K
Cardiomyopathy II: Dilated Cardiomyopathy
649
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
649
Myocarditis III: Medical Management
257
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
257
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Myocarditis IV: Nursing Management
286
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
286
Cardiomyopathy V: Interprofessional Care
520
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
520

